Συγγραφείς:
Naylor, A.R.
Ricco, J.-B.
de Borst, G.J.
Debus, S.
de Haro, J.
Halliday, A.
Hamilton, G.
Kakisis, J.
Kakkos, S.
Lepidi, S.
Markus, H.S.
McCabe, D.J.
Roy, J.
Sillesen, H.
van den Berg, J.C.
Vermassen, F.
Kolh, P.
Chakfe, N.
Hinchliffe, R.J.
Koncar, I.
Lindholt, J.S.
Vega de Ceniga, M.
Verzini, F.
Archie, J.
Bellmunt, S.
Chaudhuri, A.
Koelemay, M.
Lindahl, A.-K.
Padberg, F.
Venermo, M.
ESVS Guidelines Committee
Λέξεις-κλειδιά:
antilipemic agent; antithrombocytic agent; hydroxymethylglutaryl coenzyme A reductase inhibitor, age; Alzheimer disease; anticoagulant therapy; artery disease; Article; asymptomatic disease; blood pressure regulation; carotid artery disease; carotid artery obstruction; carotid artery stenting; carotid atherosclerosis; carotid endarterectomy; cerebrovascular accident; checklist; clinical outcome; cognitive defect; cranial nerve injury; diabetes control; diabetic patient; diagnostic imaging; disease severity; echography; general anesthesia; heart infarction; hematoma; high risk patient; human; hypertension; multiinfarct dementia; patient compliance; patient harm; patient identification; patient monitoring; perioperative period; practice guideline; preoperative period; priority journal; quality of life; randomized controlled trial (topic); revascularization; risk management; screening; secondary prevention; sex difference; survival; tertiary prevention; transient ischemic attack; vascular surgery; vertebral artery; wound drainage
